Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Suthasinee Kumluang"'
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Stroke has one of the biggest burden of disease in Thailand and all health regions have been tasked to develop their service delivery to achieve the national key performance indicators set out by the Thai service plan strategy 201
Externí odkaz:
https://doaj.org/article/984e28269c0b467ea1b29163a30b1d21
Publikováno v:
BMJ Open, Vol 13, Iss 6 (2023)
Objective To determine resource utilisation, costs and all-cause mortality related to stroke in Thailand.Design Retrospective, cross-sectional study.Setting and participants Patients with first-ever stroke in the Thai national claims database between
Externí odkaz:
https://doaj.org/article/c39ed7a167b14763a63d45d22a576c1f
Autor:
Suthasinee Kumluang, Lily Ingsrisawang, Sermsiri Sangroongruangsri, Usa Chaikledkaew, Tanapat Ratanapakorn, Paisan Ruamviboonsuk, Wongsiri Taweebanjongsin, Janejit Choovuthayakorn, Somanus Thoongsuwan, Prut Hanutsaha, Kittisak Kulvichit, Thitiporn Ratanapojnard, Warapat Wongsawad, Pattara Leelahavarong, Yot Teerawattananon
Publikováno v:
BMC Ophthalmology, Vol 19, Iss 1, Pp 1-14 (2019)
Abstract Background To evaluate the effectiveness of intravitreal bevacizumab (IVB) and intravitreal ranibizumab (IVR) in actual practice for treating patients with retinal diseases in Thailand. Methods A prospective, multi-centre, observational stud
Externí odkaz:
https://doaj.org/article/3bec2b03ce9e49a89d61e77568cda348
Autor:
Roongnapa Khampang, Sarayuth Khuntha, Phorntida Hadnorntun, Suthasinee Kumluang, Sonvanee Tanuchit, Sripen Tantivess, Yot Teerawattananon
Publikováno v:
BMJ Open Quality, Vol 8, Iss 1 (2019)
Variation in practices of and access to health promotion and disease prevention (P&P) across geographical areas have been studied in Thailand as well as other healthcare settings. The implementation of quality standards (QS)—a concise set of eviden
Externí odkaz:
https://doaj.org/article/1fb310b90ffd47619b11cf24f93cc479
Autor:
Danai Chinnacom, Pattara Leelahavarong, Suradech Doungthipsirikul, Suthasinee Kumluang, Netnapis Suchonwanich, Sripen Tantivess, Akanittha Poonchai, Nitichen Kittiratchakool
Publikováno v:
International journal of technology assessment in health care. 35(6)
ObjectivesTo explore health technology assessment (HTA) in Thailand focusing on its institutionalization, key elements for HTA introduction, and HTA contribution to policy.MethodsA review of literature covered a wide range of topics, including the in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f58a785375f80745e719294a0e7258fd
https://pubmed.ncbi.nlm.nih.gov/31190670
https://pubmed.ncbi.nlm.nih.gov/31190670
Autor:
Sri Idaiani, Thunyarat Anothaisintawee, Yot Teerawattananon, Waranya Rattanavipapong, Ully Adhie, Alia Luz, Co-investigators: Dewi Indriani, Devika Singh, Kanlaya Teerawattananon, Lily Banonah Rivai, Sarocha Chootipongchaivat, Suthasinee Kumluang, Purvi Paliwal, Nunik Kusumawardani, Priska Apsari Primastuti
Publikováno v:
Health Systems & Reform. 2:84-98
—The economic and health burden of noncommunicable diseases (NCDs) is significant globally. To counteract this problem, the World Health Organization (WHO) introduced the Package of Essential Noncommunicable disease (PEN) interventions. Several cou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0f564d501144c7e2a8e1133b749a04e
https://doi.org/10.1080/23288604.2015.1124168
https://doi.org/10.1080/23288604.2015.1124168
Autor:
Usa Chaikledkaew, Thitiporn Ratanapojnard, Wongsiri Taweebanjongsin, Pattara Leelahavarong, Janejit Choovuthayakorn, Somanus Thoongsuwan, Prut Hanutsaha, Paisan Ruamviboonsuk, Suthasinee Kumluang, Tanapat Ratanapakorn, Warapat Wongsawad, Yot Teerawattananon, Sermsiri Sangroongruangsri, Kittisak Kulvichit, Lily Ingsrisawang
Publikováno v:
BMC Ophthalmology
BMC Ophthalmology, Vol 19, Iss 1, Pp 1-14 (2019)
BMC Ophthalmology, Vol 19, Iss 1, Pp 1-14 (2019)
Background To evaluate the effectiveness of intravitreal bevacizumab (IVB) and intravitreal ranibizumab (IVR) in actual practice for treating patients with retinal diseases in Thailand. Methods A prospective, multi-centre, observational study was con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::254132b6bcef1a5ec2d62afd652fe711
https://pubmed.ncbi.nlm.nih.gov/30922350
https://pubmed.ncbi.nlm.nih.gov/30922350
Autor:
Sermsiri Sangroongruangsri, Usa Chaikledkaew, Suthasinee Kumluang, Olivia Wu, Claudia Geue, Tanapat Ratanapakorn, Pattara Leelahavarong, Lily Ingsrisawang, Paisan Ruamviboonsuk, Wongsiri Taweebanjongsin, Janejit Choovuthayakorn, Apichart Singalavanija, Prut Hanutsaha, Kittisak Kulvichit, Thitiporn Ratanapojnard, Warapat Wongsawad, Yot Teerawattananon
Publikováno v:
Clinical Drug Investigation
Background There is very limited evidence examining serious systemic adverse events (SSAEs) and post-injection endophthalmitis of intravitreal bevacizumab (IVB) and intravitreal ranibizumab (IVR) treatments in Thailand and low- and middle-income coun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c2b0fe7dfd343e9b0b098b3e053f546
http://europepmc.org/articles/PMC6827997
http://europepmc.org/articles/PMC6827997
Autor:
Sarayuth Khuntha, Sonvanee Tanuchit, Sripen Tantivess, Thunyarat Anothaisintawee, Suthasinee Kumluang, Roongnapa Khampang, Phorntida Hadnorntun, Yot Teerawattananon
Publikováno v:
BMJ Open Quality
Variation in practices of and access to health promotion and disease prevention (P&P) across geographical areas have been studied in Thailand as well as other healthcare settings. The implementation of quality standards (QS)—a concise set of eviden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e9b4c18ce38679bf0048a40526cca9e
https://doi.org/10.1136/bmjoq-2018-000491
https://doi.org/10.1136/bmjoq-2018-000491
Publikováno v:
The International journal of pharmacy practice. 19(5)
Objectives This study aimed to develop a hospital pharmaceutical service model, together with a costing template for unit cost analysis and to analyse unit costs of hospital pharmaceutical services. Methods The study was designed on the basis of acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f2750f41638d3b437cfc9b30c92255c
https://pubmed.ncbi.nlm.nih.gov/21899613
https://pubmed.ncbi.nlm.nih.gov/21899613